Navigation Links
Lotus Pharmaceuticals Announces Second Quarter 2008 Results
Date:8/18/2008

."

Second Quarter 2008 Results

Lotus Pharmaceutical's net revenue was $19.4 million in the second quarter of 2008, an increase of 51.4% from $12.8 million in the second quarter of 2007. Wholesale distribution and manufacturing revenue was $18.4 million in the second quarter of 2008, 94.8% of total revenues, an increase of 55.2% from the second quarter of 2007. This increase was because of increased sales of third- party pharmaceuticals and increased sales of the Company's Brimonidine Tartrate Eyes Drops (sold under the brand name "Mu Xin") used in the treatment of glaucoma. Retail revenue was $903,404 in the second quarter of 2008, a 28.8% increase from $701,421 in the second quarter of 2007. The Company increased its sales of pharmaceutical products through its ten retail pharmacies. Other revenues were $99,876 in the second quarter of 2008 compared to $258,487 in the second quarter of 2007 which was attributable to a decrease in research and development services.

Gross profit in the second quarter of 2008 was $9.7 million, an increase of 76.4% compared to the second quarter of 2007. Gross margin was 50.0%, up from 42.9% in the second quarter of 2007 and up from 33.7% in the first quarter of 2008. Gross margin in the year ago period benefited from the collection of $1.8 million in previously reserved allowance for sales return that lowered cost of sales and increased gross margin by 9.3%.

Operating expenses were $6.9 million in the second quarter of 2008, a 264.6% increase from $1.9 million in the second quarter of 2007. Most of the increase was because of an increase in selling expenses, which were $5.9 million in the second quarter of 2008 compared to $791,784 in the second quarter of 2007. Selling expenses increased because of a short term sales incentive program that provided higher sales commissions to sales representatives and bonuses paid to improve collections of accounts receivable. Research and development expenses were $471,24
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... 20, 2015 This year has been ... lawns. US Patented Pearl’s Premium Ultra Low Maintenance ... the country that are coming out of record bad ... number of major global concerns related to water, health, ... – the alternative to the standard, water-wasting, chemical-treated standard ...
(Date:5/20/2015)... , May 20, 2015  Health eCareers, the ... healthcare organizations with job seekers looking for the ... a new mobile and online tool dedicated exclusively ... industry. SHIFT enables employers to quickly ... travel nursing, per diem and other temporary positions, ...
(Date:5/20/2015)... 20, 2015  Cypher Genomics, Inc., a leading ... Celgene Corporation to apply Cypher,s Coral TM ... with patient response to innovative medicines. The information ... accelerate patient access to the right medicine at ... and development and potentially inform new companion diagnostics.  ...
(Date:5/20/2015)... CA, Mulhouse, France, Cambridge, MA (PRWEB) May 20, ... provider of high quality transporter assay services for ... and Pharmacology, and Rhenovia Pharma, a world leader ... neurotransmission using Translational Quantitative Systems Pharmacology supported by ... partnership agreement. , The agreement allows both companies ...
Breaking Biology Technology:Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 3
... ... DGV databases enable researchers to quickly and effectively use these invaluable resources. , ... Seattle, WA (PRWEB) July 16, 2009 -- ... (GAD) and Database of Genomic Variants (DGV). The dbGaP resource is ...
... WILMINGTON, Del., July 15 ParagonRx, a healthcare consulting ... has filed its interim analysis of a study that shows ... of opioid drugs meet FDA standards for risk evaluation and ... to the FDA during public hearings earlier this year. , ...
... - Scientists in Atlantic Canada have found a gene that ... the genetic cause of a rare disorder known as cutis ... feet and face to be loose and older looking, as ... brain. In the process, researchers found some interesting correlations with ...
Cached Biology Technology:New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix 2New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix 3Canadian researchers discover gene related to the appearance of aging 2
(Date:5/21/2015)... 2015 The Sync Project™ , a ... health, today announced a collaborative partnership with Berklee,s ... center on collaboration on original research, joint course development ... the collaboration, The Sync Project and BerkleeICE are exploring ... in the 2015-2016 academic year.  The ...
(Date:5/19/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... drugs, such as Famotidine, Cimetidine and Ranitidine, approved in the ... the fetus according to a large collaborative cohort study by ... published in the Journal of Clinical Pharmacology provides ... blocker drugs are given to women to relieve acid ...
... This release is available in French . ... over 12 million people worldwide, with more than 2 million new ... the parasite survives inside human cells. That mystery has now been ... by a team led by Dr. Martin Olivier a ...
... cell division, whether hematopoietic stem cells (HSCs) will develop ... blood cells depends on a chemical process called DNA ... laboratory of Dr. Frank Rosenbauer of the Max Delbrck ... the laboratory of Professor Sten Eirik W. Jacobsen (Lund ...
Cached Biology News:Heartburn drugs deemed safe for fetuses according to Ben-Gurion University researchers 2Major discovery opens door to leishmania treatment 2MDC scientists show how hematopoietic stem cell development is regulated 2
Human FADD Affinity Purified Polyclonal Ab...
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules...
Biology Products: